key: cord-0050379-adk18990 authors: Martín Raymondi, Diego; Hernández, Luis title: Supportive treatment of COVID 19 patients with mild respiratory failure in a primary hospital date: 2020-09-11 journal: Med Clin (Engl Ed) DOI: 10.1016/j.medcle.2020.06.003 sha: cd90c450f4c099a91803c1b68f9f46b71d63ede8 doc_id: 50379 cord_uid: adk18990 nan An overwhelming majority of respondents (61%) were physically active on their own; of those, possibly a high percentage performed activities randomly and rigorously, which would not only be ineffective, but could expose them to injury. The same risk would be taken by the rest of the respondents who use YouTube ® and social networks to do exercises, which are recommended on a non-individual basis. And much worse still, many of the Influencers in these networks do not have professional qualifications to recommend physical exercise. Most of the respondents carried out intensity (45%) and weightbearing (30%) exercises, all this added to the above mentioned scenario results in a population vulnerable to physical injuries, in fact 12% of the respondents have already suffered from some type of lockdown-related injury, and even 5% have ended up requiring surgical treatment. This study has limitations, it is an Internet survey, which therefore does not allow reliable statistical estimates to be made with the results. We also admit the impossibility of determining the exact injury of the patients, since many of these knee injuries (25% of injured) may require elective surgery once the lockdown has ended. We also do not know of those 5% of cases that have required surgery exactly what type it has been. Perhaps the great strength of this study is that it deals with a subject of great current interest, and which seeks to alert the public and the authorities about not simplifying physical activity at home. The current lockdown can increase the rate of psychic disorders, with sport being an essential prevention tool. The recommendation is to do at least 30 min of moderate intensity physical activity daily, [3] [4] [5] ideally through individualized advice from specialists in the field. Tratamiento conservador en pacientes COVID 19 con insuficiencia respiratoria ligera en un Hospital de primer nivel Clinical manifestations of SARSCOV2 ranges from mild symptoms to respiratory failure requiring mechanical ventilation and death. Different therapeutic approaches have been tested with no solid evidence, 1 or even with no placebo arm (patients without specific treatment), 2,3 as there is no certain knowledge about the mechanism that lead to respiratory failure 4,5 (immunological and inflammatory theories have been proposed. In Spain, as in many other countries of the world, due to the huge number of patients hospitalized and high mortality, specific treat- Our Hospital is a primary care Hospital without intensive care unit and samples for SARSCOV2 polymerase-chain-reaction (PCR) have to be sent to reference hospital. Between March 14th 2020 and April 12th 2020 a total of 43 COVID + patients were discharged from our hospital and 30 COVID + patients have died due to complications directly associated with SARSCOV2 infection. We have retrospectively analyzed clinical outcomes of COVID 19 + patients admitted to hospital with pneumonia and respiratory failure in whom specific treatment for SARSCOV2 was not administered. From a total of 43 patients discharged from Hospital specific treatment was not given to 6 (13.9%). In our Hospital access to specific medication is restricted to patient with positive SARSCOV2 PCR. In 4 out of 6 patients, initial negative PCR limited access to medication and all had clinical and respiratory recovery before infection diagnosis was made by PCR (3) or antibodies (1). One patient had a prolonged QT (risk of malignant arrhythmias under specific treatment) and other patient had mild infection that induced not treatment. All of them suffered mild respiratory failure evaluated by a ratio of the partial pressure of oxygen (Pao 2 ) to the fraction of inspired oxygen (Fio 2 ) (Pao 2 :Fio 2 ) higher 200 mmHg and below 300 mm Hg as well as elevation of inflammatory markers in lab tests, reflected in Table 1 . Among COVID + patients died, a total of 22 (73%) specific treatment was denied at the moment of admission due to bad short term prognosis. In these patient average age was 84.5 years and median time till death was 5 days. Our data suggest that in COVID19 + patients admitted to hospital with mild respiratory failure and elevated inflammatory markers at lab test, conservative treatment without specific medication and adequate respiratory support can be a valid alternative. Placebo arms should be valued in randomized trials or real world patients pool. We should be cautious interpretating series of patient without placebo arms. Now, more than ever, evidence based medicine should guide our practice. To the Editor: Hepatolithiasis (HTL) is endemic in some regions of Asia, but it is rare in our environment (around 1%). 1 A total of 10 patients were diagnosed with HTL from October 2011 to April 2018. Table 1 shows both preoperative and surgical characteristics. Acute cholangitis was the most common clinical manifestation. Most patients underwent an endoscopic retrograde cholangiopancreatography (ERCP) for the treatment of choledocholithiasis, 2 of them on several occasions. The left hepatic lobe (LHL) was the most common site. The diagnosis is usually made by means of magnetic resonance cholangiography (MRC) and ultrasound endoscopy can be conclusive. Of the 10 diagnosed cases, 7 (70%) were operated on. One did not accept surgical treatment and it was discarded in two cases due to comorbidity. Postoperative mortality was nil (assessed at 3 months) and morbidity is shown in Table 1 . The mean follow-up was 59 ± 27 months (range 26-88). Only one patient relapsed with choledocholithiasis (8 months after surgery), undergoing an ERCP and remaining asymptomatic after 58 months of follow-up. Case 2, 2 years after surgery, despite strict follow-up, developed a hilar stricture secondary to a Klatskin tumour with liver metastases. The patient started CHT and finally died 21 months after diagnosis. Although the HTL present in our environment is secondary (associated with cholelithiasis and choledocholithiasis) 1 and the most common clinical manifestations are cholangitis, obstructive jaundice or abdominal pain, diagnosis may be difficult due to a low clinical suspicion. In addition, the series in the West and specifically in our country are short series. 2 The presence of pneumobilia or liver microabscesses could explain this difficulty. The most important test is the MRC, although sometimes intrahepatic lithiasis can go unnoticed. Often, several ERCPs need to be performed before a diagnosis can be reached. Recently, other tests, such as endoscopic ultrasound, may give additional information to identify lithiasis and intrahepatic biliary strictures in the left segments, as well as the possibility of performing a guided cytology. 3 The treatment of these patients is based on surgery, ERCP and percutaneous cholangiography. There are many studies that show that ERCP is a good option for selected cases, although recurrence is high, the most severe intrahepatic lithiasis are hardly resolved and morbidity is not negligible. 1 Percutaneous interventional radiology shows good results, but with a high recurrence rate, although they seem better than with ERCP. 1 Most series, both Asian and Western, consider surgery to be the best treatment 1.2 , with a lower recurrence although it also shows variable morbidity (13-40%). 2 Considering surgical morbidity, postoperative infection seems to be the most frequent complication. 2 We believe that cholangitis and prior instrumentation (ERCP) may be an explanation. The appropriate choice of a broad-spectrum antibiotic as preoperative prophylaxis should be considered in the action protocol. Other complications inherent in this type of surgery, such as biliary fistula, should also be considered before making the surgical indication. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China Novel coronavirus and orthopaedic surgery: early experiences from Singapore Coronavirus disease (COVID-19): the need to maintain regular physical activity while taking precautions Sedentary behavior: emerging evidence for a new health risk Exercise as a prescription for patients with various diseases A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 Compassionate use of remdesivir for patients with severe Hydroxychloroquine in patients with COVID-19: an open-label, randomized Hypothesis for potential pathogenesis of SARS-CoV-2 infection -a review of immune changes in patients with viral pneumonia Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv The authors of the article do not have direct or indirect funding for this study.